Cytokine Storm Manufacturers, Suppliers & Companies
-
Manufacturerbased in Monmouth Junction, NEW JERSEY (USA)
CytoSorbents Corporation is a leader in critical care immunotherapy, specializing in blood purification. Its flagship product, CytoSorb® is approved in the European Union with distribution in 58 countries around the world, as an extracorporeal ...
CytoSorb Therapy - Extracorporeal Blood Purification
he CytoSorb therapy* is based on an extracorporeal blood purification procedure that was shown to effectively reduce excessive levels of inflammatory mediators (see “The Adsorber”). This is intended to alleviate the excess systemic ...
CONTACT SUPPLIER -
Manufacturerbased in Tübingen, GERMANY
Founded in 2015, Atriva Therapeutics is a biopharmaceutical company specifically pioneering the development of host-targeting antiviral therapies set up by a team of leading scientists in viral research and seasoned industry experts. The company ...
-
Manufacturerbased in Santa Rosa, CALIFORNIA (USA)
Eliaz Therapeutics is developing a novel treatment using targeted therapeutic apheresis. Our mission is to change the course of life-threatening diseases to improve survival and prevent long-term disease and disability. Eliaz Therapeutics is ...
-
Manufacturerbased in Beijing, CHINA
Sophonix Co., Ltd. was founded in July 2017 and the headquarter is located in Beijing Economical and Technological Development Zone. The company has established dual R&D centers in California and Beijing respectively. The core team possess over 15 ...
-
Manufacturerbased in Haifa, ISRAEL
Pluristem Therapeutics Inc. is a clinical-stage regenerative medicine company using placental cells and a unique, proprietary, three-dimensional (3D) technology platform to develop cell therapies for conditions such as inflammation, muscle injuries, ...
Acute Respiratory Distress Syndrome (ARDS) Associated with COVID-19
of the most common causes of death from COVID-19[1],[2],[3],[4],[5]. A cytokine storm (CS) refers to excessive and uncontrolled release of pro-inflammatory cytokines that commonly present as ...
CONTACT SUPPLIER -
Manufacturerbased in Lausanne, SWITZERLAND
AB2 Bio Ltd., located at the Innovation Park of the École Polytechnique Fédérale de Lausanne (EPFL), is a drug discovery and development company focused on developing “best in class” innovative therapies for the treatment of inflammatory diseases ...
AB2 Bio - Secondary HLH Protein
. It is characterized by severe systemic inflammation with pancytopenia, liver insufficiency, coagulopathy and neurological symptoms. The underlying cellular mechanism is the uncontrolled activation and proliferation of T lymphocytes and macrophages ...
CONTACT SUPPLIER -
Manufacturerbased in Gangnam-gu, SOUTH KOREA
MitoImmune Therapeutics Inc. is a drug discovery and development biotech company that harnesses the power of mitochondria and its proprietary technology targeting mitochondria as the source for developing new potential breakthrough therapeutics. Our ...
MIT Platform
MIT platform is a MitoImmune’s proprietary technology that is centered 7-amino indole core structure. MIT compounds based the platform have a unique capability to permeate into negatively charge mitochondrial matrix. The MIT platform inhibits ...
CONTACT SUPPLIER -
Technologybased in Boulder, COLORADO (USA)
We are developing a robust portfolio of human diagnostic tests internally and collaborate with commercial, academic and government partners. Our team consists of industry veterans, engineers and scientists with expertise in hardware and software ...
Lightdeck - Host-Response Diagnostics
We are developing point-of-care, multiplex tests for host-response biomarkers in ...
CONTACT SUPPLIER -
Manufacturerbased in Jenkintown, PENNSYLVANIA (USA)
SFA Therapeutics, Inc. is a development-stage bio-pharmaceutical startup company focused on a new advancement in the treatment of chronic inflammatory disease – the use of microbiome-derived metabolites as drugs. A completely new approach to drug ...
Microbiome
SFA Therapeutics, Inc. is a development-stage bio-pharmaceutical startup company focused on a new advancement in the treatment of chronic inflammatory disease – the use of microbiome-derived metabolites as ...
CONTACT SUPPLIER -
Manufacturerbased in Galveston, TEXAS (USA)
ChrysalisBioTherapeutics, Inc. is a clinical stage biopharmaceutical company developing regenerative drugs that mimic the body´s natural signals to activate endothelial cells and stem cells to stimulate tissue repair and restore normal tissue ...
Chrysbio - Model TP508 (Chrysalin) - Peptide Technology
TP508 is as an injectable drug used to mitigate vascular damage, hemorrhage, and inflammation observed in ARDS induced by viral infection (COVID19) or nuclear radiation. TP508 also activates stem cells to regenerate tissues and restore function. ...
CONTACT SUPPLIER -
Manufacturerbased in Vienna, AUSTRIA
Privately held OncoQR ML, based in Vienna/Austria, is a pre-clinical biotech company that offers novel therapeutic cancer vaccines based on its unique, proprietary and broadly applicable S-TIR™ (Specific Total Immune Remodulation) technology ...
Cancer Immunotherapy Technology
Cancer cells have the ability to escape our immune system´s defenses – by outsmarting checkpoint molecules on our immune cells. For more than three decades, science and industry have been working to overcome cancer’s tricky battle ...
CONTACT SUPPLIER -
Manufacturerbased in Melbourne, AUSTRALIA
Mesoblast is using its proprietary mesenchymal lineage cell technology platform to develop and commercialize innovative allogeneic cellular medicines to treat complex inflammatory diseases resistant to conventional standard of care. ...
Mesoblast - Model Remestemcel-L - Investigational Therapy Comprising Culture-expanded Mesenchymal Stromal Cells
Remestemcel-L is being developed for inflammatory diseases in children and adults including the treatment of acute graft versus host disease (aGVHD), a potentially life-threatening complication of an allogeneic bone marrow transplant (BMT). ...
CONTACT SUPPLIER -
Manufacturerbased in Deerfield, ILLINOIS (USA)
Baxter was founded in 1931, however our history doesn't have one starting point. Our commitment to addressing unmet needs was built on the shoulders of healthcare pioneers whose work resulted in first-of-its-kind innovations in IVs, renal care, ...
Baxter Oxiris - Blood Purification Set
The Oxiris set is available in select countries around the world. Oxiris is the only blood purification filter set to effectively remove inflammatory mediators, endotoxin, fluid, and uremic toxins simultaneously. ...
CONTACT SUPPLIER -
Manufacturerbased in Seattle, WASHINGTON (USA)
Pascal Biosciences Inc. (TSXV:PAS, FSE:6PB.F) is a biopharmaceutical company founded in 2013 to advance technology licensed from the University of British Columbia. We create additional value with programs licensed from other organizations and with ...
Pascal - Cannabinoid Therapeutic for Treating COVID-19
The coronavirus pandemic has triggered a massive, worldwide effort to develop effective vaccines and treatments. With a previous focus on cancer, Pascal’s scientists directed their efforts to discovering a cannabinoid-based treatment for ...
CONTACT SUPPLIER -
Manufacturerbased in Miramar, FLORIDA (USA)
Generex Biotechnology is an integrated healthcare holding company with end-to-end solutions for patient centric care from rapid diagnosis through delivery of personalized therapies. Generex is building a new kind of healthcare company that extends ...
NuGenerex - Complete Vaccine
Our Complete Vaccine™ is designed to regulate the immune system the ii-Key technology to provide a targeted, neutralizing antibody response as well as activated T cell responses to generate long-term immune memory against infectious ...
CONTACT SUPPLIER -
Technologybased in Miami, FLORIDA (USA)
We are a clinical-stage biotechnology company developing cellular therapies for aging-related and life-threatening conditions. Our lead investigational product is Lomecel-B, which is derived from culture-expanded medicinal signaling cells (MSCs) ...
Acute Respiratory Distress Syndrome (ARDS) Research Program
We are conducting a multicenter, double-blinded, randomized, placebo-controlled trial for ARDS due to COVID-19 or influenza virus infection. ARDS can be rapidly induced by a variety of insults, such as coronavirus and influenza virus infection. ...
CONTACT SUPPLIER -
Manufacturerbased in South San Francisco, CALIFORNIA (USA)
We are dedicated to realizing the potential of natural killer (NK) cells for the treatment of cancer. Our proprietary technology is designed to harness the power of these important pathogen-fighting immune cells and is uniquely capable of enhancing ...
Nkarta - Allogeneic Natural Killer Cells
Cell therapy, a new approach that uses immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. First generation approaches have focused on T-cells, which have shown great promise in hematologic ...
CONTACT SUPPLIER
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you